🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 3, randomized, observer-blinded, active-controlled trial to evaluat...
Status
Completed
Location
US135
Start Date
2019-10-14
Trial ID
NCT04120194
Treatments Being Tested
Multicentric study, Phase III; this study is a randomized, participant- and...
Status
Completed
Location
Clinical Research Institute Saltillo
Start Date
2018-03-22
Trial ID
NCT03460743
To study the effects of age on the immune system's response to flu vaccine ...
Status
Completed
Location
Vanderbilt University Medical Center
Start Date
2019-10-21
Trial ID
NCT04077424
Treatments Being Tested
Flublok was studied previously in children 6 -59 months of age and demonstr...
Status
Completed
Location
Maine Research Associates, LLC
Start Date
2013-11
Trial ID
NCT01959945
Treatments Being Tested
This is a Phase 1, single-site, comparator-controlled, dosage-escalating st...
Status
Completed
Location
University of Iowa - Infectious Disease Clinic
Start Date
2023-10-16
Trial ID
NCT05945485
The main goal of this study is to evaluate the safety, reactogenicity, and ...
Status
Completed
Location
CenExel
Start Date
2022-05-24
Trial ID
NCT05397223
A Phase 2 trial to confirm the dose and formulation, demonstrate adjuvant e...
Status
Terminated
Location
US135
Start Date
2018-09-24
Trial ID
NCT03658629
Treatments Being Tested
This Phase 2a clinical study is designed to evaluate the immunogenicity and...
Status
Completed
Location
Centre for Vaccinology (CEVAC)
Start Date
2019-12-11
Trial ID
NCT04192500
Treatments Being Tested
This randomized, partially-blinded, active comparator-controlled was conduc...
Status
Completed
Location
Optimal Sites
Start Date
2020-11-02
Trial ID
NCT04622592
Treatments Being Tested
The purpose of this study is to determine the immune response of three dose...
Status
Completed
Location
Anaheim Clinical Trials
Start Date
2014-11
Trial ID
NCT02307851
Treatments Being Tested